Search

Your search keyword '"Rupaimoole R"' showing total 101 results

Search Constraints

Start Over You searched for: Author "Rupaimoole R" Remove constraint Author: "Rupaimoole R"
101 results on '"Rupaimoole R"'

Search Results

5. Metronomic Docetaxel in PRINT Nanoparticles and EZH2 Silencing Have Synergistic Antitumor Effect in Ovarian Cancer

8. Sustained adrenergic signaling leads to increased metastasis in ovarian cancer via increased PGE2 synthesis

12. Antagonism of Tumoral Prolactin Receptor Promotes Autophagy-Related Cell Death

14. The Eph Family: Not playing nice in uterine cancer

17. Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivoby clinically significant miR-193a-3p

25. Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.

26. ATP11B mediates platinum resistance in ovarian cancer.

27. Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression.

28. A High-Throughput Small Molecule Screen Identifies Ouabain as Synergistic with miR-34a in Killing Lung Cancer Cells.

29. Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cells.

30. PRKRA /PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer.

31. FABP4 as a key determinant of metastatic potential of ovarian cancer.

32. ATP11B mediates platinum resistance in ovarian cancer.

33. Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction.

34. Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.

35. ADH1B promotes mesothelial clearance and ovarian cancer infiltration.

36. Personalized RNA Medicine for Pancreatic Cancer.

37. Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis.

38. Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression.

39. Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer.

40. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling.

41. Role of YAP1 as a Marker of Sensitivity to Dual AKT and P70S6K Inhibition in Ovarian and Uterine Malignancies.

42. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers.

43. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.

44. Improving vascular maturation using noncoding RNAs increases antitumor effect of chemotherapy.

46. Macrophage TGF- β 1 and the Proapoptotic Extracellular Matrix Protein BIGH3 Induce Renal Cell Apoptosis in Prediabetic and Diabetic Conditions.

47. Developing hyperpolarized silicon particles for in vivo MRI targeting of ovarian cancer.

48. Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth.

49. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal.

50. A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.

Catalog

Books, media, physical & digital resources